Display options
Share it on

Acta Naturae. 2015 Jan-Mar;7(1):117-20.

Recombinant α-NAcetylgalactosaminidase from Marine Bacterium-Modifying A Erythrocyte Antigens.

Acta naturae

L A Balabanova, V A Golotin, I Y Bakunina, L V Slepchenko, V V Isakov, A B Podvolotskaya, V A Rasskazov

Affiliations

  1. G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch, Russian Academy of Sciences, 100-letiya Vladivostoka Ave., 159, 690022, Vladivostok, Russia ; Far Eastern Federal University, Sukhanova Str., 8, 690950, Vladivostok, Russia.
  2. G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch, Russian Academy of Sciences, 100-letiya Vladivostoka Ave., 159, 690022, Vladivostok, Russia.
  3. Far Eastern Federal University, Sukhanova Str., 8, 690950, Vladivostok, Russia.

PMID: 25927009 PMCID: PMC4410403

Abstract

A plasmid based on pET-40b was constructed to synthesize recombinant α-N-acetylgalactosaminidase of the marine bacterium Arenibacter latericius KMM 426T (α-AlNaGal) in Escherichia coli cells. The yield of α-Al- NaGal attains 10 mg/ml with activity of 49.7 ± 1.3 U at 16°C, concentration of inductor 2 mM, and cultivation for 12 h. Techniques such as anion exchange, metal affinity and gel filtration chromatography to purify α-AlNaGal were applied. α-AlNaGal is a homodimer with a molecular weight of 164 kDa. This enzyme is stable at up to 50°C with a temperature range optimum activity of 20-37°C. Furthermore, its activity is independent of the presence of metal ions in the incubation medium. 1H NMR spectroscopy revealed that α-AlNaGal catalyzes the hydrolysis of the O-glycosidic bond with retention of anomeric stereochemistry and possesses a mechanism of action identical to that of other glycoside hydrolases of the 109 family. α-AlNaGal reduces the serological activity of A erythrocytes at pH 7.3. This property of α-AlNaGal can potentially be used for enzymatic conversion of A and AB erythrocytes to blood group O erythrocytes.

Keywords: 1H NMR spectroscopy; Arenibacter latericius; conversion of A erythrocytes; glycoside hydrolase GH109

References

  1. J Biol Chem. 2000 Dec 29;275(52):41287-98 - PubMed
  2. J Med Genet. 1996 Jun;33(6):458-64 - PubMed
  3. Mar Drugs. 2013 Jun 10;11(6):1977-98 - PubMed
  4. Biotechnol Appl Biochem. 2003 Apr;37(Pt 2):157-63 - PubMed
  5. Nat Biotechnol. 2007 Apr;25(4):454-64 - PubMed
  6. Transfus Clin Biol. 2004 Feb;11(1):33-9 - PubMed
  7. Biochem Int. 1992 Oct;28(1):77-86 - PubMed
  8. Biochemistry. 2007 Mar 20;46(11):3319-30 - PubMed

Publication Types